Research Program has focused its recent efforts on the development of small molecules (new drug therapies), sensitising brain cancer cells to radiation treatment, identifying better drug combinations and reducing chemotherapy-induced toxicity.
It takes time, teamwork and, of course, it takes money.
At HMRI we have an incredibly supportive community of donors, volunteers, staff and researchers working tirelessly to deliver better health solutions. It is the perfect environment for insightful and impactful research that is recognised nationally and internationally.
In 2014 we were gifted a very valuable and generous donation from the Mark Hughes Foundation, which enabled a new blood and tissue “biobank” to be established at the HMRI Building. Samples donated by patients during their brain cancer journey will be preserved for future exploration as knowledge and technology evolve.
The resource will help build a broader and clearer understanding of the genetic nuances in different cancers. It will allow us to determine precisely what kind of cancer someone has, what that cancer is going to mean in terms of their life, how aggressive it is and what their likely treatment response will be.
It is amazing asset and we are incredibly grateful to the Mark Hughes Foundation for an investment that will surely reap long-term benefits. The future for brain cancer patients in our community, and elsewhere, is considerably brighter thanks to Mark and Kirralee Hughes and their myriad supporters.
By Prof Nilsson
Director HMRI